stated otherwise) 1Q19 4Q18 1Q18 1Q19 YoY LTM 1Q19 LTM 1Q18 LTM YoY Production Volume (kt) 2,966 2,818 2,325 28% 11,060 9,240 20% Consolidated Revenue1,2 3,030 2,788 2,414 26% 11,357 8,811 29% Core

(except where stated otherwise) 1Q19 4Q18 1Q18 1Q19 YoY LTM 1Q19 LTM 1Q18 LTM YoY Production Volume (kt) 2,966 2,818 2,325 28% 11,060 9,240 20% Consolidated Revenue1,2 3,030 2,788 2,414 26% 11,357 8,811 29

FY2018 Bangchak Corporation Plc. I 2 Table of Content Management Discussion & Analysis of Business Operation 03 Executive Summary 05 Important Events 08 Statement of Income 10 Business Performance 10

with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000

the mentioned item had no effect on the consolidated financial statement. Performance compared to Q2/ 2018, the exploration and production business recorded a decrease in revenue by THB 489 million

Quarter 2017 2 nd Quarter 2016 Group Revenues 5,445 5,212 Group Sales Volume (k tons) (27) 660 P er fo rm an ce Group EBITDA (735) (14) HRC Sales (k tons) 302 340 HRC Production Volume (k tons) 17,252

Company increase by Baht 603 million due to resumption of production for its own sale post termination of Tolling. Total liabilities Total liabilities of the consolidated Financial Statement as at 31

Exchange of Thailand Buriram Sugar Public Company Limited and its subsidiaries (“the Company”) would like to report the operating result by considering the Company’s Financial statement for year-end

Statement ( million Baht) 3Q16 2Q17 3Q17 %YoY %QoQ 9M16 9M17 %YoY Revenue from sale of goods 199.79 227.23 224.58 12.41% -1.17% 655.30 706.68 7.84% Cost of sale of goods (139.71) (153.83) (155.85) 11.55% 1.31

3. Ms. Wannarat Termritikulchai 425,000 28.33 4. Mr. Rioishi Hori 75,000 5.00 Total 1,500,000 100.00 3) Statement of Financial Position Company’s Financial Statement (Unit: Thousand THB) Assets Dec 31